Contributor:

Anat Loewenstein MD, MHA

COVID-19: A Global Response

Tarek Hassan, MD; Paisan Ruamviboonsuk, MD; J. Fernando Arevalo, MD, PhD; and Anat Loewenstein, MD

Management of RVO

Anat Loewenstein, MD

Home-Based OCT and AMD

Anat Loewenstein, MD

MEAD: Diabetic Macular Edema Trial Subanalysis

Nikolas J.S. London, MD, Anat Lowenstein, MD

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD

Type 1 Neovascularization or CSC?

Dinah Zur, MD; and Anat Loewenstein, MD, MHA

Gearing Up for a GA Therapy

Kourous A. Rezaei, MD; and Anat Loewenstein, MD, MHA

VEGF Inhibition and Beyond: Building on Existing Foundations

Patricio Schlottmann, MD, Anat Loewenstein, MD, Charles C. Wykoff, MD, PhD

The Coming Shift in AMD Care

Anat Loewenstein, MD, MHA; and Alistair Laidlaw, MBBS, MD

Fact or Fiction: Are Integrin Inhibitors a Viable Strategy?

Carl D. Regillo, MD, FACS, David A. Eichenbaum, MD, and Anat Loewenstein, MD, MHA